Young boys who ate a greater proportion of ultraprocessed foods were more likely to develop overweight or obesity by age 5 years, according to findings published in JAMA Network Open.“Ultraprocessed ...

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...

Eaten when a boy is aged three, these kinds of products were linked to obesity by the time the child reached five.

Obesity-drug maker Metsera Inc.'s stock jumped 47% on Friday as the biggest gainer among three initial public offerings bucking a swoon in the equity market to rise in their stock-market debuts Friday ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with semaglutide.Topline results from the Phase ...

(HealthDay News) — For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated with a significantly higher rate of remission of diabetes ...

With 61% of cats and 59% of dogs overweight, the chances of overweight health complications increase significantly.

Heart disease is once again the leading cause of death in the U.S., according to a new statistical report from the American ...

Dr Eric Berg DC has warned suffering from the condition every night could put you more at risk of several chronic diseases ...

These weight loss medications, administered via injections, work by mimicking a hormone called GLP-1, which helps regulate appetite and blood sugar levels.

Dr Eric Berg DC has shared 'hidden dangers' and numerous health risks of the problem that affects many at night ...